Literature DB >> 35660928

Understanding the relationship between gliomas and T cells: Paving the way for effective immunotherapy.

Catalina Lee-Chang1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35660928      PMCID: PMC9527519          DOI: 10.1093/neuonc/noac152

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  9 in total

1.  Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Authors:  Gary Bloomgren; Sandra Richman; Christophe Hotermans; Meena Subramanyam; Susan Goelz; Amy Natarajan; Sophia Lee; Tatiana Plavina; James V Scanlon; Alfred Sandrock; Carmen Bozic
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

Review 3.  Combating immunosuppression in glioma.

Authors:  Eleanor A Vega; Michael W Graner; John H Sampson
Journal:  Future Oncol       Date:  2008-06       Impact factor: 3.404

Review 4.  Recent developments on immunotherapy for brain cancer.

Authors:  Derek A Wainwright; Pragati Nigam; Bart Thaci; Mahua Dey; Maciej S Lesniak
Journal:  Expert Opin Emerg Drugs       Date:  2012-04-25       Impact factor: 4.191

5.  The Immune Landscape of Cancer.

Authors:  Vésteinn Thorsson; David L Gibbs; Scott D Brown; Denise Wolf; Dante S Bortone; Tai-Hsien Ou Yang; Eduard Porta-Pardo; Galen F Gao; Christopher L Plaisier; James A Eddy; Elad Ziv; Aedin C Culhane; Evan O Paull; I K Ashok Sivakumar; Andrew J Gentles; Raunaq Malhotra; Farshad Farshidfar; Antonio Colaprico; Joel S Parker; Lisle E Mose; Nam Sy Vo; Jianfang Liu; Yuexin Liu; Janet Rader; Varsha Dhankani; Sheila M Reynolds; Reanne Bowlby; Andrea Califano; Andrew D Cherniack; Dimitris Anastassiou; Davide Bedognetti; Younes Mokrab; Aaron M Newman; Arvind Rao; Ken Chen; Alexander Krasnitz; Hai Hu; Tathiane M Malta; Houtan Noushmehr; Chandra Sekhar Pedamallu; Susan Bullman; Akinyemi I Ojesina; Andrew Lamb; Wanding Zhou; Hui Shen; Toni K Choueiri; John N Weinstein; Justin Guinney; Joel Saltz; Robert A Holt; Charles S Rabkin; Alexander J Lazar; Jonathan S Serody; Elizabeth G Demicco; Mary L Disis; Benjamin G Vincent; Ilya Shmulevich
Journal:  Immunity       Date:  2018-04-05       Impact factor: 43.474

Review 6.  T lymphocytes as dynamic regulators of glioma pathobiology.

Authors:  Elizabeth C Cordell; Mahmoud S Alghamri; Maria G Castro; David H Gutmann
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

7.  B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.

Authors:  Johannes Griss; Wolfgang Bauer; Christine Wagner; Martin Simon; Minyi Chen; Katharina Grabmeier-Pfistershammer; Margarita Maurer-Granofszky; Florian Roka; Thomas Penz; Christoph Bock; Gao Zhang; Meenhard Herlyn; Katharina Glatz; Heinz Läubli; Kirsten D Mertz; Peter Petzelbauer; Thomas Wiesner; Markus Hartl; Winfried F Pickl; Rajasekharan Somasundaram; Peter Steinberger; Stephan N Wagner
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

Review 8.  Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.

Authors:  Rong En Tay; Emma K Richardson; Han Chong Toh
Journal:  Cancer Gene Ther       Date:  2020-05-27       Impact factor: 5.987

Review 9.  Drainage of cells and soluble antigen from the CNS to regional lymph nodes.

Authors:  Jon D Laman; Roy O Weller
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-22       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.